Pseudomonas aeruginosa in cystic fibrosis: cross-infection and the need for segregation  by TUBBS, D. et al.
Pseudomonas aeruginosa in cystic fibrosis:
cross-infection and the need for segregation
D. TUBBS, W. LENNEY, P. ALCOCK, C.A. CAMPBELL, J. GRAY AND C. PANTIN
North Staffordshire Royal Infirmary, Stoke-on-Trent, Staffordshire, U.K.
Evidence-based reasons for segregation of patients colonized with Pseudomonas aerugionsa in the outpatient setting
are unclear. To clarify local decisions, Pseudomonas genotyping of the local environment, patients and patient
contacts was undertaken in 1993. The hospital environment was re-swabbed in 1997. Pseudomonas genotyping of
old and new patients attending the North Staffordshire cystic fibrosis clinic has subsequently been undertaken and
more recently been repeated on an annual basis to assess whether the same Pseudomonas genotypes can be found in
both the environment and in patients, and whether the same Pseudomonas genotype can be transferred from one
patient to another.
No Pseudomonas genotype found in the local environment in 1993 or in 1997 has been found in any of our
patients. Nine children attending the same special school for many years and sharing the same physiotherapy
facilities showed no evidence of cross-infectivity. Except for siblings living in the same household our cross-
infectivity rate is very low and where cross-infection has potentially occurred the level of contact between these
patients has been minimal. This study does not support the suggestion that patients with cystic fibrosis attending
the North Staffordshire clinic and colonized with Pseudomonas aeruginosa should be segregated from non-colonized
patients.
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Pseudomonas aeruginosa (PA) is the most important
pathogen in patients with cystic fibrosis (CF). It is a
Gram-negative motile rod which is undemanding in its
requirements and can live almost anywhere. In a hospital
setting it is most commonly found in a damp or moist
environment and is rarely found in healthy individuals.
Colonization of patients with PA is unusual except in CF
where the abnormal mucus of CF patients makes an ideal
environment. Once in the lungs, it adheres to the
respiratory epithelium and its exoproducts affect the
immune response. When established in the respiratory tract
PA adapts and changes to a mucoid form, becoming more
dicult to eradicate and resulting in colonization which is
usually defined as three positive sputum samples within a
period of 6 months. This is the definition we have used in
North Staffordshire in relation to our patients. Jacques
et al. (1) showed that in 6–13-year-old CF patients
colonized with PA, lung function was significantlyReceived 13 October 2000 and accepted 8 November 2000.
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0954-6111/01/020147+06 $35?00/0worse than in those not colonized. Ballmann et al. (2)
differentiated between patients colonized with non-mucoid
and mucoid forms, and found the mean annual deteriora-
tion in FEV1 worsened with a change to the mucoid
form.
The medical literature is unclear about the relationship
between PA isolated in the environment and subsequent
transmission to patients with CF (3–6), cross-infectivity
between CF patients (7–10) and the possible benefits of
patient segregation (10,11). Against this background there
is a difference of opinion as to whether patients colonized
with PA should be segregated from those not colonized by
organizing separate outpatient clinics in an attempt to
reduce cross-infection and subsequent colonization in the
vulnerable patients.
Phenotypic and genotypic methods for PA identification
have been described. Genotypic methods measure the
precise genetic make-up of the organism and are more
accurate (12). We have studied PA in our patients using a
genotypic method to assess whether cross-infectivity has
occurred to a significant degree over time. We felt that
before recommending segregation, which would involve
considerable disruption to our outpatient service, we
needed clear scientific evidence that such disruption would
be beneficial to our patients and would warrant the# 2001 HARCOURT PUBLISHERS LTD
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place. Initial testing began in 1993. We report our findings
over a 6-year period between 1993 and 1998.
Methods
PATIENTS AND METHODS
A cross-sectional study was initiated in 1993 to identify
which of our CF patients were growing PA and whether
there were any similarities in genotype. There were 46
patients in this original study accounting for 100% of the
patients attending the North Staffordshire Cystic Fibrosis
Clinic at that time. Their ages ranged from 1 to 54 years.
Between 1993 and 1998 26 new patients joined the North
Staffordshire CF Clinic from within and outside the county
borders.
In 1993 swabs were taken in the environment and from
patients in an attempt to identify any possible transmission
of PA from the environment to patients. Swabs were also
taken from close family members and the degree of contact
was noted between a patient, family members and other CF
patients attending the outpatient clinic. Members of the CF
team also had nose and throat swabs cultured for PA. It
was known in 1993 that nine patients had attended the
same special school for children with physical disabilities,
two being in the same class and two travelling to school
together. The degree of contact between patients was
arbitrarily assessed using the following simple scale:
(i) No contact;
(ii) Attended the same CF clinic;
(iii) Occasional social visits to each others houses;
(iv) Inpatient care in the same ward at the same time
(a) once or twice,
(b) frequently;
(v) Close relationships outside hospital;
(vi) CF patients within the same family.
Our cystic fibrosis clinic is of such a size that we feel we
know our patients well and through the members of the
cystic fibrosis team we can accurately place our patients
into one of the above six arbitrary categories. The
environmental sites swabbed in 1993 were from the
paediatric and adult clinics, the paediatric and adult wards
and the local special school. The main sites swabbed were
sinks, baths, toilets, lung function equipment, treatment
room surfaces etc. (There is a separate adult and paediatric
CF clinic sited in the same outpatient building. The adult
and paediatric wards are housed in different buildings some
200m apart.) The patients had nose and throat swabs taken
and wherever possible sputum samples were taken for
culture. Whenever new patients were diagnosed locally or
new patients were transferred from other districts to the
North Staffordshire CF clinic for their care (between 1993
and 1998) it was noted whether they were already colonized
with PA and genotyping of the organism was undertaken at
the earliest opportunity.Some of the patients in the original 1993 cross-sectional
study have had genotype re-testing to see if they have
acquired any new strains. It has now become our policy to
annually re-type each patient’s PA strain to identify the rate
of new strain acquisition. The hospital environment was re-
swabbed in 1997.
LABORATORY METHODS
Bacteriology
(a) Culture. All samples were cultured for PA using
standard techniques. Sputum was diluted 1 : 1 with ‘sputa-
sol’ (Oxoid SR89), homogenized and cultured directly on to
5% horse blood, MacConkey agar (Oxoid CM7) and
Burkholderia cepacia agar (Mast DM253) plates. Plates
were examined after being left overnight and after 48 h
incubation at 35–378C for the presence of PA. Nasal swabs,
throat swabs and environmental swabs were cultured on
Columbia blood agar base (Oxoid CM331), 5% horse
blood and MacConkey agar and examined in a similar
fashion. Colonies were identified by morphology, oxidase
reaction and pigmentation. A limited number of samples
was also identified by the response pattern to the AP1 20NE
(Biomerieux, France) system. All PA isolates were stored at
7208C on porous ceramic beads in a cryovial containing
glycerol.
(b) Genotyping. We used restriction endonuclease
analysis to obtain the PA genotype employing rare cutting
enzymes to produce large fragments which were then
separated by pulse field electrophoresis. Discrimination
was defined by the number of band differences between
different isolates. All strains were prepared on the same gel
with an 80% or greater match to indicate the same PA
genotype. The pulse-field gel electrophoresis method used
was essentially that of Grothues (13), modified by
Kaufmann and Pitt (14). The bacteria were grown over-
night on nutrient agar plates and then embedded into
agarose blocks. They were then incubated with proteinase
K-EDTA and subsequently digested with infrequently
cleaving enzyme X bal. The fragments were then separated
and analysed by contour clamped homogenous electric field
gel electrophoresis CHEF Mapper (Biorad).
Results
GENOTYPE RESULTS
Table 1 shows three pairs of patients (1993 cross-sectional
study) with the same three PA genotypes together with the
degree of patient contact. Table 2 shows the subsequent PA
genotypings between 1993 and 1998 found in more than
one patient together with the degree of patient contact.
Patients 47, 48 and 49, 38 and 39, are families of siblings
living in the same household. Patients 42 and 22 are
patients with prolonged and close contact.
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in the same class and two had travelled to school together
using the same transport system for 2 years. All children
shared the same school physiotherapy facilities on a dailyTABLE 2. The subsequent clusters of 10 PA genotypes found in a
Individual patient
Genotype number
S1 42
S1 22
S2 44
S2 36
S2 15
S2 56 (Dec 94)
S2 64 (June 96)
S3 28
S3 48 (March 95)
S3 60 (Dec 96)
S4 mother of 46
S4 58 (not confirmed on second dendogram)
S5 47 (May 94)
S5 48 (May 94)
S6 47 (May 94)
S6 48 (May 94)
S7 35 (Nov 93)
S7 48 (Dec 93)
S7 49 (May 94)
S8 25 (Nov 93)
S8 53 (Aug 94)
S9 38 (Jan 95)
S9 39 (Jan 95)
S10 63
S10 35
TABLE 1. The three pairs of Pseudomonas genotypes found
in paired patients with their degree of contact as found in
the 1993 cross-sectional study
Patient Degree of
Genotype individual number contact
S1 42 iv (b)
S1 22
S2 44 i
S2 36
S3 28 ii
S3 48 (Dec. 93)
Degree of contact: (i) no contact; (ii) attended the same CF
clinic; (iii) occasional social visits to each others houses; (iv)
inpatient care in the same ward at the same time (a) once or
twice or (b) frequently; (v) close relationships outside
hospital; (vi) CF patients within the same family.basis. Six became colonized with PA whilst at the school,
colonization taking place between 1 and 7 years
after school entry. None of these patients shared the same
PA genotype!
NEW PATIENTS
Twenty-six new patients began attending the North
Staffordshire CF Clinic after the original 46 patients in
the 1993 cross-sectional study. Ten were adults, eight
having been colonized with PA before arrival having
previously attended other CF clinics. Of the 16 paediatric
patients, two came from outside clinics with an established
diagnosis of CF. One patient arrived allegedly non-
colonized but his fourth throat swab 3 months after arrival
grew PA genotype S8. The same type had been found in one
patient in the 1993 cross-sectional study 9 months earlier.
The only contact between the two patients was one
outpatient clinic attendance 1 month prior to the new
patient’s PA isolation. The other new paediatric patient
grew PA soon after arrival; the genotype was unrelated to
any other genotype in our other patients. Of the remaining
14 newly diagnosed paediatric patients nine have grown
PA. One is genotype S2 which has been found in four other
patients, the degree of contact between all of them beingssociation with patients and their degree of patient contact
Degree of contact
iv (b)
i with all others having genotype S2
i with 56, 64, ii with 15 (1 clinic visit in common)
i with 44, 2 with 36, 56, 64
i with 44, 2 with 36, 15, 64
i with 44, 2 with 36, 15, 56, 64
ii (only possible contact: - one OP visit)
i
i
vi
vi
iv with 35, 48 and 49
vi with 48 and 49
ii
vi
i
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patients. Genotypes from the other two patients are not
available.
PATIENTS AND CONTACT CULTURES
In the 1993 cross-sectional study in which 25 of 46 patients
were colonized with PA, 16 patients produced 27 PA
isolates from sputum cultures and 17 isolates from mouth/
throat swabs. Swabs were taken from 222 patient contacts
of whom only one grew PA. This was from the mother of a
patient who at that time was not colonized with PA.
CONTACT QUESTIONNAIRE
The results of the questionnaire used in 1993, to assess the
degree of contact between patients, indicated the majority
had little contact with each other outside hospital and apart
from two holidays none had contact with patients from
other areas.
ENVIRONMENTAL CULTURES
In the 1993 cross-section study 182 environmental swabs
were taken yielding 35 positive PA cultures. The follow-up
environmental study in 1997 produced six positive cultures
from 46 swabs. None of the arbitrary PA genotypes in
either 1993 or 1997 were the same as any of the PA
genotypes isolated from any of the CF patients.
Discussion
THE ENVIRONMENT AND PATIENTS WITH
CF
In a multi-centre study in 1990 (3) one strain of PA was
found in 28% of isolates from patients and in 21% of
isolates from the environment (including a river, a
swimming pool and a drain 4300 km away). A second
strain was found in four patients and in standing water. A
cross-sectional study examined PA isolates from patients,
from sinks and from the hands of hospital personnel (4).
Twenty per cent of patients and 89% of sink swabs grewTABLE 3. The pattern of colonization seen in patients with cysti
1993
Number of patients 39
Number PA colonized 14
Colonized 0–4 years 0 of 5
Colonized 5–9 years 5 of 15
Colonized 10–14 years 6 of 15
Colonized 15–18 years 3 of 4
% colonized 36PA. On arrival at work all personnel had negative cultures
but 42?5% became positive during duty. Four genotypes
were isolated from the environment, none of which were
found in the patients. Transmission from sinks to hands
was shown, with PA surviving on the hands for at least
60min.
PA briefly survives in aerosols or on dry surfaces (5) but
in dried sputum can survive for 1 week and in sinks for over
6 months. In the CF lung one strain persisted for more than
8 years during which time it changed to the mucoid form.
Doring et al. (6) showed coughing of patients contami-
nated surfaces and sinks, which then contaminated hands.
Hand shaking was shown to transfer PA to clean hands for
at least 30min. Eight PA genotypes found in the environ-
ment resulted in six being isolated from patients on the
wards. Environmental genotypes were also found on health
staff workers.
In our 1993 and 1997 environmental studies many PA
genotypes were isolated but none of them was also cultured
from patients with CF. We therefore have no evidence that
the hospital environment (or the environment in the special
school attended by nine of our patients) has contributed to
the colonization of our patients with PA. Similarly it is also
true we have no evidence to suggest that patients have
contaminated the environment!
CROSS-INFECTION—THE NEED TO
SEGREGATE PATIENTS
Twenty-five patients from Hanover were genotyped (7).
Nine of 13 families with more than two affected children
had closely related PA strains. In three families, resistant
strains in one child spread to another within 6 months. One
strain was found in four patients from unconnected families
who attended the same CF outpatient clinic. Eight of 10
patients spending 6 weeks in a rehabilitation centre became
colonized with different genotypic strains, three of which
were mucoid. PA infection rate rose from 37% in 1983 to
60% in 1986.
Cross-colonization has been shown to occur in children
during recreational stays, the rate increasing the longer the
stay (8). Four months later the same strain was found in
57% of patients, the remainder having different strains.
An epidemic of multi-resistant PA was reported in
Liverpool in 1995 (9). Sixty-five of 92 patients grew thec fibrosis aged 0–18 years from 1993 to 1998
1996 1997 1998
45 46 48
23 27 28
1 of 7 2 of 8 3 of 12
4 of 10 4 of 8 5 of 8
10 of 17 11 of 17 10 of 15
8 of 11 10 of 13 10 of 11
51 59 58
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same organism was first detected in 1987. Subsequently,
four to 12 patients were infected per year. Eighty-five per
cent of these were the same strain which was not found in
the hospital environment. It seems probable that this multi-
resistant PA was transmitted by patient to patient contact.
Hoiby and Pedersen (10) used a mathematical model to
show that as their clinic size increased so did the likelihood
of cross-infection. The probability of acquisition of PA was
found to fall after patients were segregated. Mean age of
non-colonized patients rose after segregation. Swabbing the
environment revealed six out of 1000 genotypes were also
found in patients.
Tu¨mmler et al. (7) showed that between 1983 and 1986
PA colonization rose from 37% to 60%. Twelve of 14
newly colonized patients had PA genotypes identical to
those of previously colonized patients. Segregation and
general hygiene measures were taken in 1986 and 2 years
later all unrelated patients grew PA of different strains.
Our study shows an increase in the PA colonization rate
in our paediatric patients, from 36% in 1993 to 58% in
1998 (Table 3). We have also seen an increasing coloniza-
tion rate in younger patients and indeed more rapidly
following their first PA isolation. This is despite actively
and aggressively pursuing a policy of immediate treatment
with nebulized colomycin and oral ciprofloxacin for 3-
month periods in recent years. Of the newly diagnosed
paediatric patients, however, most who have grown PA
have revealed strains unrelated to our other patients, only
one revealing a strain (S2) previously found. Possible
contact with that patient could only have occurred during
one previous outpatient visit. In contrast, nine patients who
regularly attended the same special school for many years
and shared, on a daily basis, the same physiotherapy
facilities are colonized with different PA strains. This
indicates that colonized patients tend to keep their own
strains and do not easily or frequently pass on their own
strain to others. Certain ‘epidemic’ strains may well behave
differently.
As with other studies, we have shown that siblings living
in the same household often share the same PA genotype.
Patients attending the North Staffordshire CF Clinic who
share the same PA genotype, and are not siblings living in
the same household, have been found to have little contact
with each other. There is no evidence that the clinic
environment is acting as a vehicle for transfer from patient
to patient.
We do not know the total number of PA strains
occurring in our CF patients and we are therefore unable
to calculate the likelihood of two patients having the same
PA strain by chance. However, from the evidence in this
study there seems little reason to recommend the urgent
segregation of CF patients in the outpatient setting into
those colonized with PA and those not colonized. The
logistics of this are significant, the practical upheaval, the
rearrangement of the clinics and the planning of the
timetable for all members of the CF team outweigh such
changes. Compared with the largest CF centres in the U.K.
our clinic size is relatively small but comparable in size to
many others in the country. The size of the clinic may wellbe important in determining the possible need for segrega-
tion. Hygiene in the clinic is also important. We attempt to
keep our weekly clinic limited to eight patients maximum
per clinic, to spread out the patients arrival times so only a
small number are present at any one time and to have
separate cubicles for the doctors, nurse, physiotherapist,
dietician and psychologist.
It is interesting to note that although we try to segregate
CF inpatients by placing them in individual cubicles when
they are admitted for inpatient treatment, they are
frequently found together in the same cubicle watching
TV or playing on the same PlayStationTM.
We accept that all clinics do not have the facility for
genotyping PA strains and this needs to be considered when
recommending whether to segregate patients. We also
admit that in North Staffordshire we have never isolated
an epidemic strain of PA or indeed an epidemic strain of
Burkholderia cepacia. Had this occurred the conclusions
may well be different. Our present segregation policy (for
both inpatient and outpatient care) includes the isolation of
patients with Burkholderia cepacia (epidemic strains or not)
or multi-resistant Staphylococcus aureus (MRSA). Given
our low PA cross-infectivity results and considering the
above practicalities, this study does not support segregating
patients colonized with PA in our outpatient setting.
Conclusions
(1) We have shown no relationship between PA strains
isolated from the environment and PA strains isolated
from our CF patients.
(2) We have not shown any convincing evidence to
recommend the immediate isolation of patients
colonized with PA from those non-colonized in an
attempt to reduce the risk of cross-infection in the
outpatient setting.
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